CASEY TURNER: Open Payments
NPI 1851022784 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$110 in 5 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $0 · 2025 $110
Food & beverage: $110
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| PharmaEssentia USA Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Korlym, FRUZAQLA, KISQALI, BESREMI.
Industry payments across IN — which companies pay providers there.
